ICLR vs MRK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ICLR presents a stark contrast between strong deterministic health and deteriorating growth fundamentals. While the Piotroski F-Score of 7/9 indicates a strong financial foundation and the stock trades below its Graham Number ($142.86) and Book Value (P/B 0.95), the recent earnings collapse (-98.7% YoY) is a critical concern. The massive PEG ratio of 19.29 suggests the stock is significantly overvalued relative to its current growth trajectory. Despite analyst 'Buy' recommendations, the technical trend remains bearish and revenue growth has stagnated.
MRK shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
ICLR vs MRK: Head-to-Head Comparison
This page compares ICON Public Limited Company (ICLR) and Merck & Co., Inc. (MRK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.